5426502026-09-075426502026-09-072026-09-07542650Metropolis Healthcare LimitedMETROPOLISNOTLISTEDINE112L01020NewOther Restructuringfalse2026-09-0717:30:002026-09-07Metropolis Quality Solutions Private Limited (“MQSPL”), a subsidiary of Metropolis Healthcare Limited (“the Company/MHL”), has approved and entered into: (a) the Share Subscription Agreement with Medsource Ozone Biomedicals Private Limited (“Medsource”) and Dr. Puneet Kumar Nigam; and (b) the Shareholder’s Agreement (“SHA”) with Medsource, MHL and Dr. Puneet Kumar Nigam. Reason for Restructuring: The restructuring is intended to consolidate and streamline the External Quality Assessment Services Business under MQSPL, by bringing together the operational leadership, clinical / diagnostic backing, R&D, and product development capabilities required to scale the business.Medsource and Dr. Puneet will invest approximately INR 1.10 crore and INR 16 lakh, respectively, in MQSPL. Presently, MQSPL is a wholly owned subsidiary of MHL. Upon consummation of the Transaction and subject to fulfilment of the applicable terms and conditions governing the conversion, in tranches over a period of 5 (five) years, of the 10,000 Optionally Convertible Redeemable Preference Shares issued to Dr. Puneet Kumar Nigam, the shareholding structure of MQSPL, on a fully diluted basis, shall be as follows: MHL – 54.90%; Medsource – 30.60%; and Dr. Puneet – 14.50%.MHL and Medsource shall have the right to nominate Directors on the Board of MQSPL, subject to the terms of the SHA. The protective/reserved matters, along with the clearly defined roles, responsibilities, rights and obligations of each Party, shall be as set out in the SHA.falsePresently, MQSPL is a wholly owned subsidiary of MHL. Upon consummation of the Transaction and subject to fulfilment of the applicable terms and conditions governing the conversion, in tranches over a period of 5 (five) years, of the 10,000 Optionally Convertible Redeemable Preference Shares issued to Dr. Puneet Kumar Nigam, the shareholding structure of MQSPL, on a fully diluted basis, shall be as follows: MHL – 54.90%; Medsource – 30.60%; and Dr. Puneet – 14.50%.